The Beauty Health Company (SKIN)
NASDAQ: SKIN · Real-Time Price · USD
1.610
-0.050 (-3.01%)
Nov 4, 2024, 4:00 PM EST - Market closed

Company Description

The Beauty Health Company designs, develops, manufactures, markets, and sells aesthetic technologies and products worldwide.

The company’s flagship product includes HydraFacial that enhance the skin to cleanse, extract, and hydrate the skin with proprietary solutions and serums.

Its products also comprise Syndeo, a Delivery System designs to connects providers to the consumer’s preferences to create a more personalized experience; consumables, such as single-use tips, solutions, and serums used to provide a hydrafacial treatment; SkinStylus SteriLock Microsystem, a microneedling device used for the treatment of enhancing appearance of surgical or traumatic hypertrophic scars on the abdomen and facial acne scarring in Fitzpatrick skin types I, II, and III; and Keravive, a treatment for scalp health.

The company was founded in 1997 and is headquartered in Long Beach, California.

The Beauty Health Company
The Beauty Health Company logo
Country United States
Founded 1997
Industry Household & Personal Products
Sector Consumer Staples
Employees 881
CEO Marla Beck

Contact Details

Address:
2165 Spring Street
Long Beach, California 90806
United States
Phone 800 603 4996
Website beautyhealth.com

Stock Details

Ticker Symbol SKIN
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001818093
CUSIP Number 88331L108
ISIN Number US88331L1089
Employer ID 85-1908962
SIC Code 3841

Key Executives

Name Position
Marla Malcolm Beck President, Chief Executive Officer and Director
Michael P. Monahan Chief Financial Officer

Latest SEC Filings

Date Type Title
Nov 4, 2024 SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals
Oct 15, 2024 8-K Current Report
Aug 30, 2024 8-K Current Report
Aug 8, 2024 10-Q Quarterly Report
Aug 8, 2024 8-K Current Report
Jun 11, 2024 8-K Current Report
May 17, 2024 SC 13G Statement of acquisition of beneficial ownership by individuals
May 9, 2024 10-Q Quarterly Report
May 9, 2024 8-K Current Report
May 2, 2024 8-K/A [Amend] Current report